LID.L Regulatory News (LID)

24 Apr 2008 07:01

LiDCO Group Plc24 April 2008 Press Release 24 April 2008 LiDCO Group Plc ("LiDCO" or the "Company") Appointment of Group Finance Director LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, todayannounces the appointment of Paul Leighton Clifford as Group Finance Directorwith effect from 23 April 2008. Dr Terry O'Brien, CEO of LiDCO, commented: "We are delighted to welcome Paul tothe Company. He has excellent financial and commercial credentials that willplay an increasingly valuable role as LiDCO's next period of growth takes ustowards profitability and positive cashflow." Paul, aged 56, qualified as a chartered accountant with Touche Ross (nowDeloittes) and has spent over 25 years in growth technology companies. He joinsLiDCO from AIM quoted Civica plc, where he was Finance Director of its £80million turnover operating subsidiary, Civica UK Limited, from 2006 until early2008. Paul was Group Finance Director of London Stock Exchange quoted software groupComino Group plc from 1996 until it was acquired by Civica plc in early 2006.Comino floated on Aim in 1997 and moved to the Official list on 20 July 1999. In 1991, Paul co-founded and was a director of BCS Computing Limited ("BCS"), astart up company backed by venture capital funds to invest in vertical marketsoftware companies. BCS was re-organised into Comino Group in 1996. In addition to these roles, Paul has held other senior managerial and financialroles, primarily in the software and computing services sectors and hasexperience in mergers and acquisition, post- acquisition integration commercialcontracts, company secretarial matters and risk management. In accordance with Schedule 2(g) of the AIM Rules, the following information inrelation to the appointment of Paul Clifford to the Board of LiDCO Group Plc, isdisclosed below: Current Directorships Directorships held in the past five yearsPaul Clifford has no other current Directorships Civica UK Limited Comino Group plc - ENDS - For more information please contact:LiDCO Group PlcTerry O'Brien - Chief Executive Tel: +44 (0)20 7749 1500 John Rowland - Company Secretary www.LiDCO.co.uk Panmure Gordon and CoEdward Farmer/ Katherine Roe +44 (0)20 7459 3600 www.panmure.com Media enquiries Abchurch CommunicationsHeather Salmond / Stephanie Cuthbert 0207 398 7718Stephanie.cuthbert@abchurch-group.com www.abchurch-group.com About LiDCO Group Plc LiDCO is a leading supplier of minimally invasive hemodynamic monitoringequipment and disposables. These are used primarily for the management ofhospital patients requiring critical care or at major cardiovascular risk.LiDCO's computer-based technology significantly reduces the complications(particularly infections) and costs associated with major surgery. Thetechnology was invented in the Department of Applied Physiology based at StThomas' Hospital, London. LiDCO is based in the UK and its shares are traded onAIM. For more information please see www.lidco.com. The Company's manufacturing facility is in Hoxton, London and its currentproducts are: * LiDCOplus and PulseCO monitors: these computer-based platforms are used in theIntensive Care Unit for real-time continuous display of hemodynamic parametersincluding cardiac output, oxygen delivery and fluid volume (PPV% and SVV%) * LiDCO disposables: used in conjunction with the LiDCOplus Monitor for accuratemeasurement of cardiac output in a minimally invasive manner * LiDCOview: an easy-to-use graphical display of historical LiDCOplushemodynamic data. Both clinical researchers and routine users can viewbeat-to-beat hemodynamic data collected with the LiDCOplus. LiDCOviewSE is thestandard version of this tool and is available for free, allowing anyone todownload and access data from the LiDCOplus. LiDCOviewPRO is the Professionalversion, allowing users to analyse, export and report the LiDCOplus data. A freetrial of LiDCOviewPRO is available for evaluation purposes prior to purchase * LiDCOlive: a software product in development for the remote display ofhemodynamic monitoring parameters derived through use of the LiDCOplus orLiDCOrapid monitors * LiDCOrapid : our new cardiac output monitor designed specifically for use inthe Operating Theatre for fluid and drug management at the point of care Distribution Network: The Company has now achieved registration of its products in 14 markets inEurope, the USA, Brazil, South Korea and Japan. It sells direct in the UK andUSA, and elsewhere through a worldwide network of speciality critical care andanesthesia distributors. This information is provided by RNS The company news service from the London Stock Exchange